Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
Fundamentals
Mkt Cap
$1.23B
Volume
-
52W High
$22.67
52W Low
$9.40
PE Ratio
-
Avg. Volume
1.09M
EPS (Annual)
-$1.96
P/B
3.23
Rev/Employee
$102,221.15
Earnings
Nov 12
33
Bearish Sentiment
How do you feel about GENB?
shoc24
$GENB reported earnings before the open today. GAAP EPS missed estimates: -$0.68 vs. -$0.56 expected, according to Stock Meadow.
Link your Stocktwits account
Ask your agent for live sentiment, watchers, trending tickers, and news.